Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Urinary tract infection? 29 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Urinary tract infection have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 0.8% of all adverse event reports for BOTULINUM TOXIN TYPE A.

29
Reports of Urinary tract infection with BOTULINUM TOXIN TYPE A
0.8%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
12
Hospitalizations

How Dangerous Is Urinary tract infection From BOTULINUM TOXIN TYPE A?

Of the 29 reports, 12 (41.4%) required hospitalization.

Is Urinary tract infection Listed in the Official Label?

Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Hypoaesthesia (703) Nausea (665)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Urinary tract infection Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection BOTULINUM TOXIN TYPE A Demographics